0I7E.L
DaVita Inc. specializes in delivering vital kidney dialysis treatments to individuals afflicted with chronic kidney failure. The company manages numerous outpatient dialysis clinics, where it not only conducts dialysis sessions but also offers essential laboratory testing services. Its comprehensive offerings extend to outpatient, hospital inpatient, and at-home hemodialysis. Furthermore, DaVita operates its own clinical laboratories, performing standard dialysis-related tests and other prescribed analyses for ESRD patients, alongside providing management and administrative support to its network of outpatient centers. Beyond core dialysis, DaVita delivers a suite of integrated care services...[Read more]
Industry
Medical - Care Facilities
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0I7E.L
According to DaVita Inc.’s latest financial reports and current stock price. The company's current ROE is -123.56%. This represents a change of 301.51% compared to the average of -30.77% of the last 4 quarters.
The mean historical ROE of DaVita Inc. over the last ten years is 106.33%. The current -123.56% ROE has changed -216.20% with respect to the historical average. Over the past ten years (40 quarters), 0I7E.L's ROE was at its highest in in the December 2024 quarter at 214.11%. The ROE was at its lowest in in the March 2025 quarter at -60.99%.
Average
106.33%
Median
46.96%
Minimum
-114.70%
Maximum
773.06%
Discovering the peaks and valleys of DaVita Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.08%
Maximum Annual ROE = 773.06%
Minimum Annual Increase = -114.84%
Minimum Annual ROE = -114.70%
| Year | ROE | Change |
|---|---|---|
| 2025 | -114.70% | -114.84% |
| 2024 | 773.06% | 1.08% |
| 2023 | 65.48% | -16.77% |
| 2022 | 78.67% | -39.25% |
| 2021 | 129.51% | 131.61% |
| 2020 | 55.92% | 47.10% |
| 2019 | 38.01% | 783.22% |
| 2018 | 4.30% | -69.58% |
| 2017 | 14.15% | -25.25% |
| 2016 | 18.93% | 241.83% |
The current ROE of DaVita Inc. (0I7E.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
241.28%
5-year avg
186.40%
10-year avg
106.33%
DaVita Inc.’s ROE is less than Fresenius Medical Care AG & Co. KGaA (7.21%), greater than Baxter International Inc. (-16.60%), greater than Rockwell Medical, Inc. (-14.03%),
| Company | ROE | Market cap |
|---|---|---|
| 7.21% | $11.31B | |
| -16.60% | $12.59B | |
| -14.03% | $31.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DaVita Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DaVita Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is DaVita Inc.'s ROE?
How is the ROE calculated for DaVita Inc. (0I7E.L)?
What is the highest ROE for DaVita Inc. (0I7E.L)?
What is the 3-year average ROE for DaVita Inc. (0I7E.L)?
What is the 5-year average ROE for DaVita Inc. (0I7E.L)?
How does the current ROE for DaVita Inc. (0I7E.L) compare to its historical average?